{"id":"W4389704510","doi":"10.1017/s0266462323001848","title":"PP33 The Cost-effectiveness Of Regorafenib In The Treatment Of Advanced Hepatocellular Carcinoma From A Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Medicine; Hepatocellular carcinoma; Sorafenib; Cost effectiveness; Adverse effect; Quality-adjusted life year; Quality of life (healthcare); Cost-effectiveness analysis; Oncology; Internal medicine; Cancer; Colorectal cancer; Risk analysis (engineering)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002464336,0.0007033733,0.0008645303,0.001693587,0.0006994192,0.002161348,0.001038833,0.0007151687,0.008967239],"category_scores_gemma":[0.008178726,0.0003387317,0.002564511,0.00224585,0.0005121712,0.0005498271,0.0006669105,0.0009279087,0.0002941604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06231008,"about_ca_system_score_gemma":0.0737744,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9589626,"about_ca_topic_score_gemma":0.9469493,"domain_scores_codex":[0.9981481,0.0006624628,0.00006826364,0.0001316483,0.0006243573,0.0003652341],"domain_scores_gemma":[0.9978582,0.0008184382,0.0001786985,0.00004641457,0.0008618855,0.0002362503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002484639,0.0001743999,0.03959347,0.002668841,0.002926815,0.0006159456,0.0002208271,0.7317303,0.001302154,0.05823364,0.03105797,0.128991],"study_design_scores_gemma":[0.002372941,0.00118591,0.1007143,0.002822564,0.00660162,0.001132931,0.0008932876,0.7449036,0.001922367,0.02677497,0.1101765,0.0004989041],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5631329,0.09079483,0.02810757,0.04414974,0.0005975961,0.001629041,0.0880423,0.0004622581,0.1830838],"genre_scores_gemma":[0.9712747,0.01176462,0.006652168,0.0007531818,0.00008134859,0.0001667329,0.004996894,0.00004301193,0.004267389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06231008,"threshold_uncertainty_score":0.4520934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03142847871220281,"score_gpt":0.4230383136949414,"score_spread":0.3916098349827386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}